Switching Antidepressants: 31% Report Symptoms, Tailor Your Taper

Learn how to switch antidepressants with a taper guided by your clinician, compare methods, and tell withdrawal from relapse using current evidence.
72 Hour Plan for U.S. ADHD Medication Shortages

A clinician-tested 72-hour triage for U.S. patients: assess supply, call pharmacies, notify your prescriber, and use telehealth to coordinate urgent ADHD…
DSM Thresholds Explained: Panic Disorder vs Generalized Anxiety

Clinician led, evidence first comparison of panic disorder and generalized anxiety. Learn DSM timing rules, key symptoms, and when to seek psychiatric care.
Five Clinician Clues to Distinguish Depression From Burnout in Adults

A psychiatrist’s evidence based checklist for adults: five clinician clues to separate burnout from depression, citing WHO, NIMH, and systematic reviews.
Stay OCR Ready: Telepsychiatry Privacy and HIPAA for U.S. Clinicians

U.S. clinicians: telepsychiatry privacy and HIPAA steps. Match HHS/OCR expectations with BAAs, secure platforms, consent and breach checks.
Keep Your ADHD Stimulant Rx Through Dec 31, 2026: U.S. Telehealth Rules

How U.S. telehealth lets DEA registered clinicians prescribe ADHD stimulants through Dec 31, 2026, and what patients must do to keep refills.
Clinicians: When to Use Augmentation for Depression, NNT 9–19

Measurement focused clinician summary of antidepressant augmentation: key agents, NNT 9–19, and criteria for escalating to TMS or ketamine.
Antidepressants While Breastfeeding: Clinician Evidence on RID Under 10%

Clinician focused evidence on antidepressant use while breastfeeding. Explains RID thresholds, sertraline and paroxetine safety, and practical infant…
FDA Warns: How U.S. Clinicians Manage Benzodiazepine Dependence Safely

A U.S. clinician explainer on benzodiazepine dependence: what FDA, ASAM, CDC/NIDA say, plus safe outpatient taper steps and when to seek emergency care.
0.5 mg/kg Start: Outpatient Ketamine Infusion Protocol for Clinics

Clinic guide to outpatient IV ketamine using the evidence backed 0.5 mg/kg over 40 minutes regimen. Covers screening, monitoring, dosing schedule, safety,…